IGF2 and central nervous system cancer: In the first dataset, IGF2 was highly expressed in a subset of glioma cells, whereas the IGF2 receptors were highly expressed in TME cell types, including endothelial cells, pericytes, oligodendrocytes, and myeloid cells (Figure 4D).